AHFS Drug Information August 2023 Update

This update contains 11 new monographs, 10 revised monographs, and 1 new MedWatch alert.

New monographs: Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl; Bexaglifozin; Coagulation Factor IX (Recombinant), Glycopegylated; Epcoritamab-bysp; Fecal microbiota spores, live-brpk; Fezolinetant; Perfluorohexyloctane; Rezafungin acetate; Somapacitan-beco; Sulbactam Sodium and Durlobactam Sodium; Zavegepant Hydrochloride.

Revised monographs: Benralizumab; Bexarotene; Binimetinib; Ferric Derisomaltose; Ivosidenib; Nilutamide; Nintedanib Esylate; Sirolimus; Tacrolimus; Zanubrutinib.

New MedWatch alerts on the following monograph: Semaglutide.